Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. appendix 2), notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel, Reagent Resource Support for AIDS Vaccine Development.
Date: October 24, 2002.
Time: 12 p.m. to 2 p.m.
Agenda: To review and evaluate contract proposals.
Place: 6700-B Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Alec Ritchie, Phd, Scientific Review Administrator, NIAID, DEA, Scientific Review Program, Room 2223, 6700B Rockledge Drive, MSC-7616, Bethesda, MD 20892-7616, (301) 496-2550.Start Printed Page 60690
(Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS)Start Signature
Dated: September 19, 2002.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 02-24374 Filed 9-25-02; 8:45 am]
BILLING CODE 4140-01-M